体细胞NLRC4嵌合致晚发型自身炎症性疾病首例描述
研究报告一例57岁女性,47岁起反复发热、肌痛、关节痛、腹痛、腹泻、淋巴结病及全身炎症,抗IL-1药物控制良好。NGS未检出已知自身炎症基因胚系变异,但发现NLRC4 p.Ser171Phe嵌合变异(等位基因分数2-4%),功能与结构分析证实其功能获得性,为晚发型未分类自身炎症性疾病的诊断评估提供依据。
要点
- 晚发型未分类自身炎症性疾病需考虑体细胞嵌合变异,NLRC4 p.Ser171Phe嵌合是 plausible 病因。
- NLRC4 p.Ser171Phe嵌合变异经功能与结构研究证实为功能获得性,与既往NLRC4致病变异一致。
- 抗IL-1药物可较好控制该患者反复发热、肌痛、关节痛等全身炎症表现。
核心结论
- 体细胞NLRC4 p.Ser171Phe嵌合变异可能是该晚发型未分类自身炎症性疾病患者的病因。
- 功能与结构研究首次证实该变异具有功能获得性,与既往报道的NLRC4致病变异一致。
研究设计与样本
- 病例研究,对一例57岁女性晚发型未分类自身炎症性疾病患者进行遗传学与功能分析。
- 采用Sanger测序与二代测序(NGS)检测基因变异,并开展计算机模拟、体外及离体分析验证变异功能后果。
主要发现
- 患者47岁起反复发热、肌痛、关节痛、弥漫性腹痛、腹泻、淋巴结病及全身炎症,抗IL-1药物控制相对良好。
- NGS未在已知自身炎症性疾病相关基因中检出胚系变异,但在外周血未分级样本中检出NLRC4 p.Ser171Phe变异,等位基因分数2-4%,符合基因嵌合。
- 结构建模提示该错义变异可能促进NLRC4蛋白开放活性构象,体外与离体分析证实其倾向寡聚化并激活NLRC4炎症小体,随后IL-18过度产生。
关键数值与推荐
- NLRC4 p.Ser171Phe变异等位基因分数为2-4%,符合基因嵌合。
- 功能与结构分析证实该变异具有功能获得性,支持其为致病性变异。
临床怎么用
- 对成年起病的未分类自身炎症性疾病患者,诊断评估中应考虑体细胞嵌合变异的可能。
- NLRC4嵌合变异可通过NGS在血液中检出,等位基因分数较低时需结合功能分析确认致病性。
- 抗IL-1药物可作为NLRC4相关自身炎症性疾病的有效治疗选择。
局限性
- 研究仅基于单例病例,结论的普遍性需更多病例验证。
- 原文未报告长期随访数据及抗IL-1药物的具体剂量与疗效量化指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Autoinflammatory diseases are inherited disorders of innate immunity that usually start during childhood. However, several recent reports have described an increasing number of patients with autoinflammatory disease starting in adulthood. This study was undertaken to investigate the underlying cause of a case of late-onset uncharacterized autoinflammatory disease. METHODS: Genetics studies were performed using Sanger sequencing and next-generation sequencing (NGS) methods. In silico, in vitro, and ex vivo analyses were performed to determine the functional consequences of the detected variant. RESULTS: We studied a 57-year-old woman who at the age of 47 years began to have recurrent episodes of fever, myalgias, arthralgias, diffuse abdominal pain, diarrhea, adenopathies, and systemic inflammation, which were relatively well controlled with anti-interleukin-1 (anti-IL-1) drugs. NGS analyses did not detect germline variants in any of the known autoinflammatory disease-associated genes, but they identified the p.Ser171Phe NLRC4 variant in unfractionated blood, with an allele fraction (2-4%) compatible with gene mosaicism. Structural modeling analyses suggested that this missense variant might favor the open, active conformation of the NLRC4 protein, and in vitro and ex vivo analyses confirmed its propensity to oligomerize and activate the NLRC4 inflammasome, with subsequent overproduction of IL-18. CONCLUSION: Our findings indicate that the postzygotic p.Ser171Phe NLRC4 variant is a plausible cause of the disease in the enrolled patient. Functional and structural studies clearly support, for the first time, its gain-of-function behavior, consistent with previously reported NLRC4 pathogenic variants. These novel findings should be considered in the diagnostic evaluation of patients with adult-onset uncharacterized autoinflammatory disease.
引用
- Ionescu D, Peñín-Franch A, Mensa-Vilaró A, et al. First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism. Arthritis Rheumatol. 2022. PMID: 34672126. doi:10.1002/art.41999
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。